DArecca James
SEC CIK 1583903 · EDGAR
Most active insiders at PBH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zerillo Jeffrey | Senior VP Ops | — | $246.4K |
| 2 | BYOM JOHN E | Dir | — | $178.1K |
| 3 | Rosado Jose Luis | See Remarks | — | — |
| 4 | Kelly John F. | Dir | — | — |
| 5 | Mekhail Adel | EVP, Marketing, Sales | — | — |
| 6 | DArecca James | Dir | — | — |
| 7 | ZIER DAWN M. | Dir | — | — |
| 8 | Sacco Christine | CFO, COO | — | — |
| 9 | Lombardi Ronald M. | CEO, Dir | — | — |
| 10 | P'Pool William | See Remarks | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 16:07 | 2026-08-04 | PBH | Prestige Consumer Healthcare Inc. | DArecca James | Dir | A - Grant | $0.00 | +2,981 | 9,572 | +45% | $0 | |
| 2026-05-19 17:34 | 2026-05-15 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | F - Tax | $56.29 | -2,505 | 25.1K | -9% | -$141.0K | |
| 2026-05-19 17:34 | 2026-05-15 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | A - Grant | — | +29.3K | 54.4K | +117% | — | |
| 2026-05-05 16:24 | 2026-05-01 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | F - Tax | $59.26 | -655 | 27.6K | -2% | -$38.8K | |
| 2025-08-06 | 2025-08-05 | PBH | Prestige Consumer Healthcare Inc. | DArecca James | Dir | A - Grant | $0.00 | +2,094 | 6,591 | +47% | $0 | |
| 2025-06-03 | 2025-05-30 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | F - Tax | $69.38 | -5,864 | 28.3K | -17% | -$406.8K | |
| 2025-06-03 | 2025-05-30 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | A - Grant | $0.00 | +12.2K | 34.2K | +56% | $0 | |
| D | 2025-05-20 | 2025-05-16 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | A - Grant | — | +7,111 | 21.9K | +48% | — |
| M | 2025-05-19 | 2025-05-15+ | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | F - Tax | $70.00 | -1,868 | 14.8K | -11% | -$130.8K |
| 2025-05-05 | 2025-05-02 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | F - Tax | $63.85 | -654 | 16.7K | -4% | -$41.8K | |
| 2024-08-07 | 2024-08-06 | PBH | Prestige Consumer Healthcare Inc. | DArecca James | Dir | A - Grant | $0.00 | +2,202 | 4,497 | +96% | $0 | |
| D | 2024-05-21 | 2024-05-17 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | A - Grant | — | +4,439 | 17.3K | +34% | — |
| M | 2024-05-17 | 2024-05-15+ | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | F - Tax | $95.71 | -763 | 12.9K | -6% | -$73.0K |
| 2024-05-06 | 2024-05-02 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | F - Tax | $93.33 | -432 | 13.7K | -3% | -$40.3K | |
| 2023-08-03 | 2023-08-01 | PBH | Prestige Consumer Healthcare Inc. | DArecca James | Dir | A - Grant | $0.00 | +2,295 | 2,295 | New | $0 | |
| D | 2023-05-17 | 2023-05-16 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | F - Tax | $89.21 | -349 | 14.1K | -2% | -$31.1K |
| D | 2023-05-17 | 2023-05-15 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | A - Grant | — | +4,205 | 14.5K | +41% | — |
| 2023-05-04 | 2023-05-02 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | F - Tax | $81.66 | -430 | 10.2K | -4% | -$35.1K | |
| D | 2022-05-18 | 2022-05-16 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | A - Grant | — | +4,774 | 10.7K | +81% | — |
| D | 2022-05-04 | 2022-05-02 | HAE | HAEMONETICS CORP | DArecca James | EVP, CFO | A - Grant | — | +5,902 | 5,902 | New | — |
| D | 2021-08-12 | 2021-08-12 | TXMD | TherapeuticsMD, Inc. | DArecca James | CFO | S - Sale+OE | $0.87 | -93.3K | 123.8K | -43% | -$81.2K |
| D | 2021-08-12 | 2021-08-10 | TXMD | TherapeuticsMD, Inc. | DArecca James | CFO | M - OptEx | — | +217.2K | 217.2K | New | — |
Purchase Sale Sale after option exercise All abbreviations